Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights

Journal of Cellular and Molecular Medicine

Kaveh Baghaei¹  Tarun Agarwal²  Tapas Kumar Maiti²  Babak Negahdari³  Bahare Shokoohian⁴  Massoud Vosough⁵  Moustapha Hassan⁶  Manuchehr Abedi‐Valugerdi⁶  Mustapha Najimi⁷  Hamidreza Aboulkheyr Es⁸ 

[1] Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran;Department of Biotechnology, Indian Institute of Technology, Kharagpur, India;Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran;Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran;Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran;Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran;Laboratory Medicine, Karolinska Institutet, Experimental Cancer Medicine, Clinical Research Center (KFC), Novum, Karolinska University Hospital‐Huddinge and Biomolecular and Cellular Medicine (BCM, Stockholm, Sweden;Laboratory Medicine, Karolinska Institutet, Experimental Cancer Medicine, Clinical Research Center (KFC), Novum, Karolinska University Hospital‐Huddinge and Biomolecular and Cellular Medicine (BCM, Stockholm, Sweden;Laboratory of Pediatric Hepatology and Cell Therapy, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium;School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia;

关键词: gene therapy;    hepatocellular carcinoma;    immune checkpoint inhibitors;    immunotherapy;    molecular‐targeted therapy;    radionuclide therapy;   

DOI  :  10.1111/jcmm.16875

来源: Wiley

【 授权许可】

CC BY